Abstract:Background Nearly 50 pathogenic genes and hundreds of pathogenic variants have been identified in monogenic autoinflammatory diseases (AIDs). Nonetheless, there are still many genes for which the pathogenic mechanisms are poorly understood, and the pathogenicity of many candidate variants needs to be determined. Objective Monogenic AIDs are a group of rare genetic diseases characterized by inflammation as the phenotype. With the development of next-generation sequencing, pathogenic genes have been widely reported and used for clinical screening and diagnosis. The International Society for Systemic Autoinflammatory Diseases (ISSAID) has recognized approximately 50 pathogenic genes and hundreds of related pathogenic variants in monogenic AIDs. We plan to investigate these pathogenic variants by conducting a variant burden analysis in order to determine whether or not there are consistent characteristics. Methods We performed a variant burden analysis on the gnomAD cohort using the currently reported genetic variants in monogenic AIDs, analyzing the enrichment of allelic signatures and deleterious predictions at the variants. Allelic signatures were extracted from gnomAD, and the deleterious predictions were extracted from existing tools. The features obtained from the variant burden analysis were applied to the Random Forest model to classify the pathogenicity of novel mutations. Results Functional enrichment and network analysis of AIDs pathogenic genes have hinted at the possible involvement of unsuspected signals. The variant burden analysis demonstrated that the pathogenicity of a variant could not be reliably classified using only its allele frequency and deleterious predictions. However, variants of varying classifications of pathogenicity exhibited strikingly different patterns of the allelic signature in the upstream and downstream regions surrounding the variants. Furthermore, the distribution of deleterious variants surrounding the variants in the cohort varied significantly across pathogenicity categories. Finally, the cohort-based features extracted from the alleles were applied to the prediction of pathogenicity in monogenic AIDs, achieving superior prediction performance compared to other tools. The cohort-based features have potential applications across a more extensive variety of disease categories. Conclusion The pathogenicity of a variant can be effectively classified based on the variant frequency and deleterious prediction of the allele in the cohort, and this information can be used to improve the accuracy of the current classification of the pathogenicity of the variant. Clinical Implications Cohort-driven pathogenicity prediction can improve the effectiveness of detecting pathogenic variants in monogenic autoinflammatory disorders.

Cohort-driven variant burden analysis and pathogenicity identification in monogenic autoinflammatory disorders

Pathophysiology, clinical manifestations and current management of IL-1 mediated monogenic systemic autoinflammatory diseases, a literature review

Single-Center Overview of Pediatric Monogenic Autoinflammatory Diseases in the Past Decade: A Summary and Beyond

Mapping the genetic landscape of disorders on the autoimmune-autoinflammatory continuum: potential implications for classification and treatment

Remote preparation of a single-mode photonic qubit by measuring field quadrature noise.

Investigating the sources of variable impact of pathogenic variants in monogenic metabolic conditions

Using Functional Genomic Data in Monocytes/Macrophages and Genotyping to Nominate Disease-Driving Single Nucleotide Polymorphisms and Target Genes in Juvenile Idiopathic Arthritis

Cardiovascular Disease Pathogenicity Predictor (CVD-PP): A Tissue-Specific In Silico Tool for Discriminating Pathogenicity of Variants of Unknown Significance in Cardiovascular Disease Genes

Protective conditioning against GVHD and graft rejection after combined organ and hematopoietic cell transplantation.

Genetic variations in NLRP3 and NLRP12 genes in adult-onset patients with autoinflammatory diseases: a comparative study

Leveraging genetic correlation across immune-mediated disease to gain insights into underpowered studies of rare conditions

Major Causes of Conflicting Interpretations of Variant Pathogenicity in Rare Disease: A Systematic Analysis

Characterizing the pathogenicity of genetic variants: the consequences of context

Endophenotype effect sizes support variant pathogenicity in monogenic disease susceptibility genes

“Teach a 1000 Teachers”: A methodology for the rapid ramp-up of photovoltaics manpower required for India's national solar mission

Refined Mapping of Autoimmune Disease Associated Genetic Variants with Gene Expression Suggests an Important Role for Non-Coding RNAs

Integrated analysis of variants and pathways in genome-wide association studies using polygenic models of disease

Mitigating Range Ambiguity in High PRF Radar using Inter-Pulse Binary Coding

Assessing the function of genetic variants in candidate gene association studies

Diagnostic yield of next-generation sequencing in suspect primary immunodeficiencies diseases: a systematic review and meta-analysis